# Dexmedetomidine and Esmolol Early Post Operative Cognitive Dysfunction

> **NCT03892512** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Beni-Suef University** · enrollment: 58 (estimated)

## Conditions studied

- Cognitive Dysfunction

## Interventions

- **DRUG:** Esmolol Hydrochloride
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT03892512
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03892512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03892512, "Dexmedetomidine and Esmolol Early Post Operative Cognitive Dysfunction". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03892512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*